BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34064594)

  • 1. Whole Body Low Dose Computed Tomography (WBLDCT) Can Be Comparable to Whole-Body Magnetic Resonance Imaging (WBMRI) in the Assessment of Multiple Myeloma.
    Ippolito D; Giandola T; Maino C; Gandola D; Ragusi M; Bonaffini PA; Sironi S
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34064594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).
    Gleeson TG; Moriarty J; Shortt CP; Gleeson JP; Fitzpatrick P; Byrne B; McHugh J; O'Connell M; O'Gorman P; Eustace SJ
    Skeletal Radiol; 2009 Mar; 38(3):225-36. PubMed ID: 19009290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of Whole-Body MRI Short Protocols in Bone Lesion Detection in Multiple Myeloma Patients.
    Ippolito D; Giandola T; Maino C; Gandola D; Ragusi M; Brambilla P; Bonaffini PA; Sironi S
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34201122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
    Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
    Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging.
    Treitl KM; Ricke J; Baur-Melnyk A
    Skeletal Radiol; 2022 Jan; 51(1):43-58. PubMed ID: 34031705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma.
    Ippolito D; Giandola T; Maino C; Pecorelli A; Ragusi M; Porta M; Gandola D; Franzesi CT; Sironi S
    Ann Hematol; 2021 May; 100(5):1241-1249. PubMed ID: 33660034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C; Hulin C; Latrabe V; Lascaux A; Bordenave L; Hindié E; Marit G
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma.
    Gundesen MT; Asmussen JT; Haukås E; Schubert M; Abildgaard N; Schjesvold F; Lund T
    Eur J Haematol; 2022 May; 108(5):423-429. PubMed ID: 35113466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body low-dose computed tomography in multiple myeloma staging: Superior diagnostic performance in the detection of bone lesions, vertebral compression fractures, rib fractures and extraskeletal findings compared to radiography with similar radiation exposure.
    Lambert L; Ourednicek P; Meckova Z; Gavelli G; Straub J; Spicka I
    Oncol Lett; 2017 Apr; 13(4):2490-2494. PubMed ID: 28454425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
    Ippolito D; Talei Franzesi C; Spiga S; Besostri V; Pezzati S; Rossini F; Sironi S
    Br J Haematol; 2017 May; 177(3):395-403. PubMed ID: 28233900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
    Jouvet JC; Thomas L; Thomson V; Yanes M; Journe C; Morelec I; Bracoud L; Durupt F; Giammarile F; Berthezene Y
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):176-85. PubMed ID: 23331931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiological diagnostics of multiple myeloma].
    D'Anastasi M; Grandl S; Reiser MF; Baur-Melnyk A
    Radiologe; 2014 Jun; 54(6):556-63. PubMed ID: 24927658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).
    Zacchino M; Bonaffini PA; Corso A; Minetti V; Nasatti A; Tinelli C; Dore R; Calliada F; Sironi S
    Eur Radiol; 2015 Nov; 25(11):3382-9. PubMed ID: 25987427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body Magnetic Resonance Imaging in Psoriatic Arthritis, Rheumatoid Arthritis, and Healthy Controls: Interscan, Intrareader, and Interreader Agreement and Distribution of Lesions.
    Poulsen AEF; Axelsen MB; Poggenborg RP; Eshed I; Krabbe S; Glinatsi D; Møller JM; Østergaard M
    J Rheumatol; 2021 Feb; 48(2):198-206. PubMed ID: 32541078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone disease in multiple myeloma. A study of 237 cases].
    Scutellari PN; Orzincolo C; Bagni B; Feggi L; Franceschini F; Spanedda R
    Radiol Med; 1992 May; 83(5):542-60. PubMed ID: 1631329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.
    Horger M; Fritz J; Thaiss WM; Ditt H; Weisel K; Haap M; Kloth C
    Skeletal Radiol; 2018 Mar; 47(3):351-361. PubMed ID: 29222688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.